Phathom Pharmaceuticals, Inc. [PHAT]

Source: 

Company Overview

Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Our initial approved products, VOQUEZNA TRIPLE PAK and VONOPRAZAN DUAL PAK, as well as our current product candidate, VOQUEZNA, contain vonoprazan, an oral small molecule PCAB.